Aya Sugyo

1.1k total citations
65 papers, 848 citations indexed

About

Aya Sugyo is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Aya Sugyo has authored 65 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Radiology, Nuclear Medicine and Imaging, 30 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Aya Sugyo's work include Radiopharmaceutical Chemistry and Applications (23 papers), Cell Adhesion Molecules Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Aya Sugyo is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (23 papers), Cell Adhesion Molecules Research (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Aya Sugyo collaborates with scholars based in Japan, United States and France. Aya Sugyo's co-authors include Atsushi B. Tsuji, Hitomi Sudo, Tsuneo Saga, Tatsuya Higashi, Mitsuru Koizumi, Kotaro Nagatsu, Chisato Yoshida, Okio Hino, Chizuru Sogawa and Yoshikazu Kurosawa and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Aya Sugyo

63 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aya Sugyo Japan	19	364	311	272	198	109	65	848
Hitomi Sudo Japan	17	289 0.8×	235 0.8×	246 0.9×	167 0.8×	100 0.9×	56	766
Morten Persson Denmark	17	305 0.8×	352 1.1×	232 0.9×	210 1.1×	270 2.5×	25	876
Nadège Gaborit France	18	264 0.7×	449 1.4×	370 1.4×	156 0.8×	65 0.6×	24	773
Xiaoxia Xu China	18	249 0.7×	310 1.0×	174 0.6×	142 0.7×	155 1.4×	54	731
Anton G.T. Terwisscha van Scheltinga Netherlands	19	507 1.4×	460 1.5×	293 1.1×	247 1.2×	104 1.0×	30	1.0k
Arris J. Henderson United States	8	320 0.9×	424 1.4×	454 1.7×	128 0.6×	186 1.7×	8	1.0k
Véronique Garambois France	15	274 0.8×	306 1.0×	296 1.1×	162 0.8×	92 0.8×	32	775
Gang Ren China	20	474 1.3×	270 0.9×	288 1.1×	251 1.3×	83 0.8×	62	1.0k
Sanne A. M. van Lith Netherlands	17	252 0.7×	246 0.8×	382 1.4×	176 0.9×	234 2.1×	33	881
Thorsten Poethko Germany	16	847 2.3×	266 0.9×	247 0.9×	99 0.5×	66 0.6×	21	1.2k

Countries citing papers authored by Aya Sugyo

Since Specialization

Citations

This map shows the geographic impact of Aya Sugyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aya Sugyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aya Sugyo more than expected).

Fields of papers citing papers by Aya Sugyo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aya Sugyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aya Sugyo. The network helps show where Aya Sugyo may publish in the future.

Co-authorship network of co-authors of Aya Sugyo

This figure shows the co-authorship network connecting the top 25 collaborators of Aya Sugyo. A scholar is included among the top collaborators of Aya Sugyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aya Sugyo. Aya Sugyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsuji, Atsushi B., Yutian Feng, Yongxiang Zheng, et al.. (2025). Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties. Nuclear Medicine and Biology. 146-147. 109043–109043. 1 indexed citations

Sugyo, Aya, et al.. (2023). Wnt1 induces osteoblastic changes in a well‐established osteolytic skeletal metastatic model derived from breast cancer. Cancer Reports. 6(12). e1909–e1909. 2 indexed citations

Sudo, Hitomi, Atsushi B. Tsuji, Aya Sugyo, et al.. (2023). Head‐to‐head comparison of three chelates reveals DOTAGA promising for ²²⁵Ac labeling of anti‐FZD10 antibody OTSA101. Cancer Science. 114(12). 4677–4690. 4 indexed citations

Tsuji, Atsushi B., Hitomi Sudo, Aya Sugyo, et al.. (2023). Novel Auger-Electron-Emitting 191Pt-Labeled Pyrrole–Imidazole Polyamide Targeting MYCN Increases Cytotoxicity and Cytosolic dsDNA Granules in MYCN-Amplified Neuroblastoma. Pharmaceuticals. 16(11). 1526–1526. 2 indexed citations

Hihara, Fukiko, Hiroki Matsumoto, Mitsuyoshi Yoshimoto, et al.. (2022). In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized 64Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study. International Journal of Molecular Sciences. 23(10). 5807–5807. 3 indexed citations

Sugyo, Aya, Atsushi B. Tsuji, Hitomi Sudo, et al.. (2022). In vivo validation of the switch antibody concept: SPECT/CT imaging of the anti-CD137 switch antibody Sta-MB shows high uptake in tumors but low uptake in normal organs in human CD137 knock-in mice. Translational Oncology. 23. 101481–101481. 5 indexed citations

Sudo, Hitomi, Atsushi B. Tsuji, Aya Sugyo, et al.. (2021). FZD10‐targeted α‐radioimmunotherapy with ²²⁵Ac‐labeled OTSA101 achieves complete remission in a synovial sarcoma model. Cancer Science. 113(2). 721–732. 24 indexed citations

Maekawa, Kazunari, Atsushi B. Tsuji, Atsushi Yamashita, et al.. (2021). Translocator protein imaging with 18F-FEDAC-positron emission tomography in rabbit atherosclerosis and its presence in human coronary vulnerable plaques. Atherosclerosis. 337. 7–17. 10 indexed citations

Tsuji, Atsushi B., et al.. (2021). Quantitative Radionuclide Imaging Analysis of Enhanced Drug Delivery Induced by Photoimmunotherapy. International Journal of Molecular Sciences. 22(15). 8316–8316.

10.

Tsuji, Atsushi B., Hitomi Sudo, Aya Sugyo, et al.. (2021). In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([189, 191Pt]cisplatin) Emitting Auger Electrons. International Journal of Molecular Sciences. 22(9). 4622–4622. 9 indexed citations

11.

Sudo, Hitomi, Atsushi B. Tsuji, Aya Sugyo, et al.. (2021). Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma. Cells. 10(10). 2503–2503. 12 indexed citations

12.

Jin, Zhao-Hui, Atsushi B. Tsuji, Mélissa Degardin, et al.. (2020). Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer. Clinical Cancer Research. 26(23). 6230–6241. 11 indexed citations

13.

Yoshii, Yukie, Hideaki Tashima, Yuma Iwao, et al.. (2020). Immuno-OpenPET: a novel approach for early diagnosis and image-guided surgery for small resectable pancreatic cancer. Scientific Reports. 10(1). 4143–4143. 16 indexed citations

14.

Sudo, Hitomi, Atsushi B. Tsuji, Aya Sugyo, et al.. (2020). Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression. International Journal of Molecular Sciences. 21(7). 2304–2304. 6 indexed citations

15.

Sugyo, Aya, et al.. (2020). Proof of Concept Study for Increasing Tenascin-C-Targeted Drug Delivery to Tumors Previously Subjected to Therapy: X-Irradiation Increases Tumor Uptake. Cancers. 12(12). 3652–3652. 5 indexed citations

16.

Sudo, Hitomi, Atsushi B. Tsuji, Aya Sugyo, et al.. (2019). Therapeutic efficacy evaluation of radioimmunotherapy with ⁹⁰Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma. Cancer Science. 110(5). 1653–1664. 10 indexed citations

17.

Fujiwara, Kentaro, Atsushi B. Tsuji, Hitomi Sudo, et al.. (2019). 111In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis. Annals of Nuclear Medicine. 34(1). 13–23. 12 indexed citations

18.

Sugyo, Aya, Atsushi B. Tsuji, Katsuyuki Minegishi, et al.. (2018). α‐particle therapy for synovial sarcoma in the mouse using an astatine‐211‐labeled antibody against frizzled homolog 10. Cancer Science. 109(7). 2302–2309. 30 indexed citations

19.

Sugyo, Aya, Atsushi B. Tsuji, Hitomi Sudo, et al.. (2018). Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic Cancer. International Journal of Molecular Sciences. 19(10). 2979–2979. 15 indexed citations

20.

Furukawa, Takako, Mélissa Degardin, Aya Sugyo, et al.. (2016). αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4. Molecular Cancer Therapeutics. 15(9). 2076–2085. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact